We've found
797 Migraine Headaches
clinical trials
Traumatic Brain Injury (TBI) Clinical Trial
Managing MTBI-related Headaches With rTMS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Headache, Migraine Clinical Trial
Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 3/1/2018
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Headache Clinical Trial
Psilocybin for the Treatment of Migraine Headache
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cluster Headache Clinical Trial
Psilocybin for the Treatment of Cluster Headache
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology, Other, Reproductive Clinical Trial
Dexmedetomidine and Propofol for Pediatric MRI Sedation
Status: Enrolling,
Phase
IV
Updated: 5/1/2018
Click here to add this to my saved trials
Neurology Clinical Trial
Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block
Status: Enrolling
Updated: 3/21/2018
Click here to add this to my saved trials
Musculoskeletal, Neurology Clinical Trial
Mindfulness and Migraine Research Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Migraine More than15 Days Per Month and Lasting 4 Hours a Day or Longer Clinical Trial
ASIS for Botox in Chronic Migraine
Status: Upcoming,
Phase
I, II
Updated: 6/22/2015
Click here to add this to my saved trials
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry Clinical Trial
Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department
Status: Upcoming,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Occipital Blocks for Acute Migraine
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Imaging the Migraine Brain Pre- and Post-Erenumab
Status: Upcoming,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Rheumatology, Other, Reproductive Clinical Trial
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Postdural Puncture Headache Clinical Trial
Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Rheumatology, Other, Reproductive Clinical Trial
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 5/4/2016
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 5/4/2016
Click here to add this to my saved trials
Migraine Headaches Clinical Trial
Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches
Status: Enrolling
Updated: 4/8/2018
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Musculoskeletal, Neurology Clinical Trial
Vagus Nerve Stimulation: Treatment for Gulf Veterans With Gulf War Illness
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
797 Migraine Headaches
clinical trials
Traumatic Brain Injury (TBI) Clinical Trial
Updated: 12/31/1969
Managing MTBI-related Headaches With rTMS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Headache, Migraine Clinical Trial
Updated: 3/1/2018
Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 3/1/2018
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Headache Clinical Trial
Updated: 12/31/1969
Psilocybin for the Treatment of Migraine Headache
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cluster Headache Clinical Trial
Updated: 12/31/1969
Psilocybin for the Treatment of Cluster Headache
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
Updated: 12/31/1969
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
Updated: 12/31/1969
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
Updated: 12/31/1969
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology, Other, Reproductive Clinical Trial
Updated: 5/1/2018
Dexmedetomidine and Propofol for Pediatric MRI Sedation
Status: Enrolling,
Phase
IV
Updated: 5/1/2018
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 3/21/2018
Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block
Status: Enrolling
Updated: 3/21/2018
Click here to add this to my saved trials
Musculoskeletal, Neurology Clinical Trial
Updated: 12/31/1969
Mindfulness and Migraine Research Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Migraine More than15 Days Per Month and Lasting 4 Hours a Day or Longer Clinical Trial
Updated: 6/22/2015
ASIS for Botox in Chronic Migraine
Status: Upcoming,
Phase
I, II
Updated: 6/22/2015
Click here to add this to my saved trials
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department
Status: Upcoming,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Occipital Blocks for Acute Migraine
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Imaging the Migraine Brain Pre- and Post-Erenumab
Status: Upcoming,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Rheumatology, Other, Reproductive Clinical Trial
Updated: 12/31/1969
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Postdural Puncture Headache Clinical Trial
Updated: 12/31/1969
Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
Updated: 12/31/1969
Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Rheumatology, Other, Reproductive Clinical Trial
Updated: 12/31/1969
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
Updated: 5/4/2016
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 5/4/2016
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
Updated: 5/4/2016
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 5/4/2016
Click here to add this to my saved trials
Migraine Headaches Clinical Trial
Updated: 4/8/2018
Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches
Status: Enrolling
Updated: 4/8/2018
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Musculoskeletal, Neurology Clinical Trial
Updated: 12/31/1969
Vagus Nerve Stimulation: Treatment for Gulf Veterans With Gulf War Illness
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials